Key details
Sponsor
Boryung Pharmaceutical Co., Ltd
Enrollment target
~1,000 participants
Primary completion
April 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
19 Years and older
Last updated December 2024